Bair Hugger Infection Cases Nominated for Bellwether Trials

A group of about three dozen hip infection lawsuits and knee infection lawsuits have been nominated for potential bellwether trials in the federal litigation over the 3M Bair Hugger warming blanket, which are designed to help gauge how juries may respond to certain evidence and testimony that will be raised in more than 1,300 similar claims brought nationwide. 

The 3M Bair Hugger is a forced-air warming blanket that is commonly found in operating rooms nationwide, which is used during most hip and knee replacement procedures. However, individuals nationwide are now pursuing product liability lawsuits against 3M Company and its Arizant Healthcare subsidiary, alleging that the device increases the risk of severe and debilitating infections.

Plaintiffs claim that the forced air warming system disrupts the laminar airflow of the operating room, causing bacteria and other contaminants from the floor to enter the area around the open surgical site, leading to deep joint infections that typically require multiple surgical procedures and lengthy treatment.

Learn More About

Bair Hugger Lawsuits

Bair Hugger warming blankets may be the cause of knee or hip surgery infections.

Learn More SEE IF YOU QUALIFY FOR COMPENSATION

Throughout the federal court system, Bair Hugger infection cases are currently centralized for pretrial proceedings before U.S. District Judge Joan Ericksen in the District of Minnesota, as part of an MDL, or multidistrict litigation.

Judge Ericksen has been presiding over the coordinated exchange of discovery and the preparation of a group of 150 randomly selected cases for a series of bellwether trials that will begin next year to help the parties evaluate the relative strengths and weaknesses of their cases.

On April 7, the parties submitted bellwether nominations (PDF), identifying 34 cases that will be eligible for the first trial dates. Each side identified 16 cases from the general pool, with one case overlapping, resulting in 31 total cases. Plaintiffs and defendants also each identified two additional cases specifically filed in Ramsey County, Minnesota, with one of the cases overlapping, for a total of three.

These bellwether nominated cases will go through limited case-specific discovery, before the list is further narrowed down to 8 representative case that will be included in a Final Bellwether Trial Pool.

Following the completion of bellwether case discovery, challenges to the admissibility of expert witness testimony and any dispositive motions, Judge Ericksen has indicated that the first trial will commence on February 8, 2018.

Although the outcome of the Bair Hugger bellwether trials will not be binding on other cases in the litigation, they will be closely watched by lawyers involved in the cases and may help facilitate eventual hip and knee infection settlements to avoid the need for hundreds of individual trials in courts nationwide.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted 2 days ago)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 3 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 4 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.